SI-BONE is excited to announce the successful completion of enrollment for the STACI clinical trial (110 patients, 15 sites). To commemorate this special occasion, SI-BONE's CEO, Laura Francis, joined Dr. Jackie Weisbein, one of our clinical investigators, and Study Coordinator Sarah Porter in the celebration. A heartfelt thank you to all the participants, site staff, and investigators for their incredible dedication and hard work in making this trial possible. The STACI study—a prospective, multicenter clinical trial evaluating the iFuse TORQ® Implant System for SI joint fusion. The study aims to demonstrate the device’s effectiveness in achieving its intended outcomes. Learn more about the study here: https://bit.ly/48y4wNV NCT05870488. More information about all our clinical trials click here: https://bit.ly/4h6vm3N #SIBONE #STACITrial #ClinicalResearch #SIJointDysfunction #SIJD
SI-BONE
Medical Device
Santa Clara, California 21,382 followers
Sacropelvic Solutions
About us
SI-BONE® is focused on helping patients in one of the most under-served, under-diagnosed, and under-treated areas in orthopedics, the sacroiliac (SI) joint. SI-BONE developed an innovative, patented implant to fuse the SI joint. The iFuse Implant System® provides a less invasive alternative to traditional sacroiliac (SI) joint fusion surgery and has been used in over 65,000 procedures to date. There are potential risks associated with the iFuse Implant System. It may not be appropriate for all patients and all patients may not benefit. For additional information on the company or the products including risks and benefits, please visit www.si-bone.com/risks. We are aware of active recruitment scams using the SI-BONE name, in which individuals pose as our recruiters and post fake remote job openings and make fake job offers on the Internet. Please note, we will never make an offer of employment without conducting multiple rounds of interviews face-to-face using secure video-conferencing technology. We will never ask candidates to cash checks or make a payment in order to be considered for a position. SI-BONE only uses company email addresses, which contain “@si-bone.com” to communicate with candidates. If you believe you’ve been a victim of a phishing scam, please visit the Cybersecurity & Infrastructure Security Agency at https://www.cisa.gov/be-cyber-smart/report-incident learn how to report it.
- Website
-
http://si-bone.com
External link for SI-BONE
- Industry
- Medical Device
- Company size
- 201-500 employees
- Headquarters
- Santa Clara, California
- Type
- Public Company
- Founded
- 2008
- Specialties
- Orthopaedic Spine and Neurosurgery
Locations
-
Primary
471 El Camino Real
Suite 101
Santa Clara, California 95050, US
Employees at SI-BONE
-
Dan Schaeffer, PMP
Program Manager | Specializing in Medical Devices, Biotechnology, and Bioinformatics
-
Helen Loh
Board Director | Digital Marketing and Transformation Leader | Growing and Creating Brands from Start-Ups to F500 Companies
-
Doug Farnham
-
Tony Recupero
President, Commercial Operations at SI-BONE
Updates
-
📢 Join Us for the SI-BONE Virtual Peer-to-Peer Series! Whether you’re looking to refine your approach or stay ahead of the curve with cutting-edge advancements, these sessions are not to be missed! 🔹 October 22 – Dr. Patterson will guide you through the process of identifying SIJF candidates in your practice. Gain practical insights and tips that you can apply immediately. 🔹 October 29 – Don’t miss Dr. Jung as he shares groundbreaking developments in pelvic fixation & fusion techniques and provides an update on the exciting STACI clinical trial. 👉Register here 10.22.24 - Dr. Denis Patterson: https://bit.ly/4hae3z0 10.29.24 - Dr. Michael Jung: https://bit.ly/4eF5Tga #SIBONE #Webinars #SIJointFusion #PeerLearning #iFuseTORQ #IFuseINTRAX #AllograftImplantSystem
-
💥iFuse 3D porous surface self-harvests bone during press fit implantation and mimics cancellous bone for ongrowth and ingrowth. 👉Click here to listen to the full video and why Dr. Alexander Molinari recommends iFuse Implant System® from SI-BONE. https://bit.ly/3zNdZEw #Lowerbackpain #SIJointDysfunction #SIJointFusion #SIBONE #QualityofLife #iFuse #SIJD
-
SI-BONE is thrilled to be participating in the Orthopaedic Trauma Association 2024 Annual Meeting in Montreal, Canada, from October 23-26! Come visit us in booth #342 to learn more about our FDA breakthrough device, the iFuse TORQ TNT™ Implant System. 📅 Don’t miss the Luncheon Industry Session on Thursday, October 24th in Conference Room 516C, where Drs. John-David Black, Charles Moon, and Edward Westrick* will discuss The Latest Evolution in Pelvic Trauma Surgery. (*SI-BONE Consultants) 🚨 Space is limited, so be sure to register here! https://bit.ly/48bHhsX ✅ Check out iFuse TORQ TNT™ on our website: https://bit.ly/4h0uOfY #OTA2024 #iFuseTORQTNT #TraumaSurgery #PelvicTrauma #BreakthroughDevice #SurgeonEducation
-
Sacroiliac (SI) joint disorders require appropriate interpretation of a patient’s history, clinical exam results, and imaging studies. Check out the full video of Dr.Travis Loidolt, Orthopedic Spine Surgeon and patient Kate describe the impact of SI joint pain. https://bit.ly/3NenpMa #Lowerbackpain #SIJointDysfunction #SIJointFusion #SIBONE #QualityofLife #iFuse #SIJD
-
📢 Speichern Sie das Datum DKOU (Deutscher Kongress für Orthopädie und Unfallchirurgie) 🌍 Berlin 📅 22-25 Oktober 2024 Wir freuen uns, Sie auf unserem Lunch Symposium mit Prof. Dr. E. Gercek* und Prof. Dr. C. Neuerburg* auf der DKOU am 23.10.24 zu begrüßen. Für Informationen vorab kontaktieren Sie uns direkt unter [email protected] oder besuchen Sie uns an unserem Stand Hall 4.2 #30. Wir freuen uns auf Sie. #lowerbackpain #SIJoint #sacropelvicsolutions *Consultant of SI-BONE.
-
We are thrilled to announce a monumental milestone in patient care! SI-BONE has successfully completed the first-in-patient procedure using the FDA breakthrough device designated iFuse TORQ TNT™ Implant System. This marks a significant step forward in the treatment of pelvic fragility fractures, providing a major improvement over the current standard of care. Click here to learn more about iFuse TORQ TNT and contact a rep: https://bit.ly/4h0uOfY View Press Release: https://bit.ly/3BALGJI #iFuseTORQTNT #BreakthroughDevice #SIBONE #InnovationInAction #SurgicalExcellence #Trauma #MedicalInnovation #Orthopaedics
-
Low back pain may impact up to 30% of Americans over the age of 18. With such a high incidence it’s important to understand all possible pain generators, including the sacroiliac (SI) joint. To learn more: https://bit.ly/3Wluv7u #Lowbackpain #SIJointDysfunction #SIBONE #SIJointFusion
-
View the full video where Dr. Douglas Kasow, and iFuse patient Cheryl, talk about the diagnosis and treatment of SI joint dysfunction: https://bit.ly/3XQP4Yu During a physical exam, a variety of assessments such as the Fortin Finger Test and SI joint provocative tests, can be performed to help determine if the SI joint is contributing to a patient’s symptoms. #Lowerbackpain #SIJointDysfunction #SIJointFusion #SIBONE #QualityofLife #iFuse #SIJD
-
Join us for a Virtual Discussion of Emerging Strategies in Spinopelvic Fixation. We are excited to host an engaging session with the renowned spine surgeons, Dr. Isador Lieberman and Dr. William Lavelle. Gain valuable insights into the latest strategies and innovations in spinopelvic fixation and take part in an interactive Q&A session. Register today! https://bit.ly/4den3Q4 #SpinopelvicFixation #SpineSurgery #QandA #MedicalWebinar #Surgeons #HealthcareInnovation #Orthopedics #SpinalHealth #Surgery #DrIsadorLieberman #DrWilliamLevelle
Similar pages
Browse jobs
Stock
SIBN
NASDAQ
20 minutes delay
$12.81
-0.41 (-3.101%)
- Open
- 13.2
- Low
- 12.73
- High
- 13.52
Data from Refinitiv
See more info on